TZ-101

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameTZ-101
Drug Alias NameGDP-fucose protein O-fucosyltransferase 1 - TargazymePeptide-O-fucosyltransferaseFtv1+Gdp-FucoseTZ-101ASC-101
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionFucosyltransferase replacements
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesLymphoma, Non-HodgkinHodgkin Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmerica Stem Cell
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargazyme Inc
Active IndicationsN/A
Inactive IndicationsMyelodysplastic SyndromesLymphoma, Non-HodgkinHodgkin Disease +[6] 

Other Information

ATC CodeN/A
Related LinksN/A